Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs

By Nilsson Peter M.   Cifkova Renata  

Pharmaceuticals, Vol. 4, Iss. 1, 2010-12 ,pp. : 1-6

MDPI

Access to resources Recommend Favorite

Anti-Diabetic Effects of CTB-APSL Fusion Protein in Type 2 Diabetic Mice

By Liu Yunlong   Gao Zhangzhao   Guo Qingtuo   Wang Tao   Lu Conger   Chen Ying   Sheng Qing   Chen Jian   Nie Zuoming   Zhang Yaozhou   Wu Wutong   Lv Zhengbing   Shu Jianhong  

Marine Drugs, Vol. 12, Iss. 3, 2014-03 ,pp. : 1512-1529

MDPI

Access to resources Recommend Favorite

Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects

By Pereira Thiago Melo Costa   Pimenta Fabio Silva   Porto Marcella Lima   Baldo Marcelo Perim   Campagnaro Bianca Prandi   Gava Agata Lages   Meyrelles Silvana Santos   Vasquez Elisardo Corral  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-08 ,pp. : 1273-1273

MDPI

Access to resources Recommend Favorite

Anti-Diabetic Effect of Portulaca oleracea L. Polysaccharideandits Mechanism in Diabetic Rats

By Bai Yu   Zang Xueli   Ma Jinshu   Xu Guangyu  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-07 ,pp. : 1201-1201

MDPI

Access to resources Recommend Favorite

Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids

By Kawser Hossain Mohammed   Abdal Dayem Ahmed   Han Jihae   Yin Yingfu   Kim Kyeongseok   Kumar Saha Subbroto   Yang Gwang-Mo   Choi Hye Yeon   Cho Ssang-Goo  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 569-569

MDPI

Access to resources Recommend Favorite